Back

Sex, comorbidities, and mortality in tricuspid regurgitation: Reassessing risk beyond valve severity

31 August 2026 (08:15 - 08:40)
Organised by: Logo
Congress Presentation Part of: Atrioventricular valve disease and ventricular function Tricuspid Valve Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nour Karra

Sheba Medical Center, Tel Hashomer (Israel)

2 More presentations in this session

Presentation thumbnail
Force–frequency–guided pacing improves cardiac output and attenuates severe functional tricuspid regurgitation
Doctor Y. Li (Shanghai, CN)
Abstract
Presentation thumbnail
Long-term outcomes after mitral valve surgery in a 25-year nationwide cohort with age-dependent prosthesis effects
Doctor J. Huang (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Atrioventricular valve disease and ventricular function

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular function and systolic pressure effect on survival of patients with tricuspid regurgitation
28 August 2020
thumbnail
Congress Presentation
Impact of sex on management and survival in aortic stenosis
30 August 2020
thumbnail
Congress Presentation
Sex-specific differences in right heart remodeling and patient outcomes in secondary tricuspid regurgitation
29 August 2025
thumbnail
Congress Presentation
Impact of significant preprocedural mitral regurgitation on mortality after transcatheter aortic valve implantation
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources